Company: COPL-UN
Filing Date: 2025-04-01
Form Type: S-1/A
Source: 0001829126-25-002247
Chunk: 393

Company: Copley Acquisition Corp
Filing Date: 2025-04-01
Form: S-1/A
Chunk 393
---
 our obligations to indemnify our officers and directors.

Our officers and directors have
agreed to waive any right, title, interest or claim of any kind in or to any monies in the trust account, and have agreed to waive any
right, title, interest or claim of any kind they may have in the future as a result of, or arising out of, any services provided to us
and will not seek recourse against the trust account for any reason whatsoever (except to the extent they are entitled to funds from
the trust account due to their ownership of public shares). Accordingly, any indemnification provided will only be able to be satisfied
by us if (i) we have sufficient funds outside of the trust account or (ii) we consummate an initial business combination.

Insofar as indemnification for
liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing
provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities
Act and is therefore unenforceable.

Item 15. Recent Sales of Unregistered Securities.

On December 3, 2024, our
sponsor paid certain offering costs that aggregated to $25,000 in exchange for 5,750,000 founder shares. Such securities were issued
in connection with our organization pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
Our sponsor is an accredited investor for purposes of Rule 501 of Regulation D.

Our sponsor has
committed, pursuant to a written agreement, to purchase from us an aggregate of 517,143 placement units (or 573,393 placement units
if the over-allotment option is exercised in full) for an aggregate purchase price of $3,875,000 (or $4,268,750 if the over-
allotment option is exercised in full). This purchase will take place on a private placement basis simultaneously with the
completion of our initial public offering. This issuance will be made pursuant to the exemption from registration contained in
Section 4(a)(2) of the Securities Act.

<div align='center'>II-1</div>

Item 16.

Exhibits and Financial Statement Schedules.

<div align='center'>EXHIBIT INDEX</div>

| Exhibit 
 No.     |     | Description                                                                                                        |
| 1.1     |     | Form of Underwriting Agreement.**                                                                                  |
|